Korea United Pharm Inc. (KRX:033270)
South Korea · Delayed Price · Currency is KRW 20,800
-50 (-0.24%)
At close: Aug 8, 2025, 3:30 PM KST
Korea United Pharm Market Cap
Korea United Pharm has a market cap or net worth of 303.82 billion as of August 14, 2025. Its market cap has decreased by -14.13% in one year.
Market Cap
303.82B
Enterprise Value
n/a
Revenue
161.44B
Ranking
n/a
PE Ratio
16.38
Stock Price
20,800.00
Market Cap Chart
Since January 22, 2001, Korea United Pharm's market cap has increased from 34.22B to 303.82B, an increase of 787.91%. That is a compound annual growth rate of 9.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2025 | 303.82B | 13.41% |
| Dec 30, 2024 | 267.89B | -35.75% |
| Dec 28, 2023 | 416.97B | 18.68% |
| Dec 29, 2022 | 351.33B | -51.95% |
| Dec 30, 2021 | 731.24B | -28.69% |
| Dec 30, 2020 | 1,025.43B | 262.16% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 74.02T |
| Celltrion | 38.80T |
| ALTEOGEN | 24.00T |
| Yuhan | 8,487.38B |
| Peptron | 8,130.78B |
| SK Biopharmaceuticals | 7,846.99B |
| PharmaResearch | 6,909.12B |
| LigaChem Biosciences | 5,648.08B |